Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune Medical Devices Ltd.'s MarginProbe(TM)

January 7, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAESAREA, Israel--(BUSINESS WIRE)--Dune Medical Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use.

Twitter
LinkedIn
Facebook
Email
Print

Asia